Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1220-1228

  Su, Tung Ping ^a   Schmidt, Peter J ^a   Danaceau, Merry ^a   Murphy, Dennis L ^a   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CLOMIPRAMINE; CORTICOTROPIN; FLUOXETINE; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUTEAL PHASE; MENSTRUAL CYCLE; NEUROENDOCRINE SYSTEM; ORAL DRUG ADMINISTRATION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ADULT; AFFECT; BEHAVIOR; FEMALE; FOLLICULAR PHASE; HORMONES; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; NEUROSECRETORY SYSTEMS; PIPERAZINES; PREMENSTRUAL SYNDROME; REFERENCE VALUES; SELF CONCEPT; SEROTONIN AGONISTS;

EID: 0030904367     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1220     Document Type: Article

References (55)

1. Eriksson E, Humble M. 1990 Serotonin in psychiatric pathophysiology: a review of data from experimental and clinical research. In: Pohl R, Gershon S, eds. The biological basis of psychiatric treatment. Basel: Karger; 66-119.
2. Linnoila M, Virkkunen M, George T, Higley D. 1993 Impulse control disorders. Int Clin Psychopharmacol. 8:53-56.
3. Wurtman JJ. 1990 Carbohydrate craving: relationships between carbohydrate intake and disorders of mood. Drugs. 39:49-52.
4. Keck Jr PE, Hudson JI, Dorsey CM, Campbell PI. 1991 Effect of fluoxetine on sleep: letter to the editor. Biol Psychiatry. 29:618-625.
5. Backstrom T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J. 1983 Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med. 45:503-507.
6. Ashby Jr CR, Carr LA, Cook CL, Steptoe MM, Franks DD. 1988 Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry. 24:225-233.
7. Ashby Jr CR, Carr LA, Cook CL, Steptoe MM, Franks DD. 1990 Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. J Neural Transm [Gen Sect]. 79:41-50.
8. Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su TP. 1987 Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol. 70:533-537.
9. Menkes DB, Coates DC, Fawcett JP. 1994 Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord. 32:37-44.
10. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G. 1991 Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med. 21:305-312.
11. Dinan TG, Barry S, Yatham LN, Mobayed M, O'Hanlon M. 1990 The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle. Int Clin Psychopharmacol. 5:119-123.
12. Veeninga AT, Westenberg HGM. 1992 Serotonergic function and late luteal phase dysphoric disorder. Psychopharmacology. 108:153-158.
13. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. 1988 Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry. 45:167-172.
14. Hollander E, DeCaria CM, Nitescu A, et al. 1992 Serotonergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses of oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry. 49:21-28.
15. Charney DS, Woodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. 1988 Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry. 45:177-185.
16. Charney DS, Woods SW, Goodman WK, Heninger GR. 1987 Serotonin function in anxiety: II. effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology. 92:14-24.
17. Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW. 1991 Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Biol Psychiatry. 30:973-984.
18. Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH. 1994 Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry. 151:1626-1630.
19. Brewerton TD, Mueller EA, Lesem MD, et al. 1992 Neuroendocrine responses to m-chlorophenylpiperazine and 1-tryptophan in bulimia. Arch Gen Psychiatry. 49:852-861.
20. Owen Jr RR, Gutierrez-Esteinou R, Hsiao J, et al. 1993 Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. Arch Gen Psychiatry. 50:636-644.
21. Krystal JH, Seibyl JP, Price LH, et al. 1993 m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenia patients: evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Arch Gen Psychiatry. 50:624-635.
22. Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE. 1995 Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Biol Psychiatry. 37:740-749.
23. Spitzer RL, Williams JB, Gibbon M, First MB. 1989 Structured clinical interview for DSM-III-R patient. New York: Biometrics Research Department, New York State Psychiatric Institute.
24. Schnurr PP. 1989 Measuring amount of symptom change in the diagnosis of premenstrual syndrome. Psychol Assess. 1:277-283.
25. Rubinow DR, Roy-Byrne PP, Hoban MC, Gold PW, Post RM. 1984 Prospective assessment of menstrually related mood disorders. Am J Psychiatry. 141:684-686.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Association.
27. Murphy DL, Mueller EW, Hill JL, Tolliver TJ, Jacobsen FM. 1989 Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology. 98:275-282.
28. Klemm W, Gupta D. 1975 A routine method for the radioimmunoassay of plasma cortisol without chromatography. In: Gupta D, ed. Radioimmunoassay of steroid hormones. Weinheim: Verlag Chemie; 143-151.
29. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GW, Loriaux DL. 1984 Corticotropin stimulation test: an aid in the evaluation of patients with Cushing's syndrome. N Engl J Med. 310:622-627.
30. Odell WD, Rayford PL, Ross GT. 1967 Simple partially automated method for radioimmunoassay of human thyroid stimulating, growth, luteinizing and follicle stimulating hormone. J Lab Clin Med. 70:973-980.
31. Aubert AL, Becker RL, Saxena BB, Raiti S. 1974 Report of the National Pituitary Agency Collaborative Study of the radioimmunoassay of human prolactin. J Clin Endocrinol Metab. 38:1115-1120.
32. Abraham GE, Swerdloff R, Tulchinsky D, Odell WD. 1971 Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab. 32:619-624.
33. Steiner M, Haskett RF, Carroll BJ. 1980 Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand. 62:177-190.
34. Pigott TA, Zohar J, Hill JL, et al. 1991 Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biol Psychiatry. 29:418-426.
35. Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M. 1991 Ethanol-like properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients [Letter]. Arch Gen Psychiatry. 4:383.
36. Blau JN. 1987 The patient observed. In: Blau NJ, ed. Migraine: clinical and research aspects. Baltimore: Johns Hopkins University Press; 3-30.
37. Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB. 1989 Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain. 37:223-227.
38. Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL. 1989 Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease: a controlled study. Arch Gen Psychiatry. 46:542-549.
39. Moss HB, Yao JK, Panzak GL. 1990 Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry. 28:325-338.
40. Halbreich U, Tworek H. 1993 Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med. 23:1-27.
41. Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE. 1993 Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry. 33:496-504.
42. Kahn RS, Wetzler S, van Praag NM. 1988 Behavioral indications of serotonin receptor hypersensitivity in patients with panic disorder. Psychiatry Res. 25:101-104.
43. Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM. 1990 Serotonin receptor sensitivity in major depression. Biol Psychiatry. 28:358-362.
44. Rubinow DR, Hoban MC, Grover GN, et al. 1988 Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol. 158:5-11.
45. Rabin DS, Schmidt PJ, Campbell G, et al. 1990 Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J Clin Endocrinol Metab. 71:1158-1162.
46. 1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can J Psychiatry. 38:662-664.
47. Brewerton TD. 1989 Seasonal variation of serotonin function in humans: research and clinical implications. Ann Clin Psychiatry. 1:153-164.
48. Brown PJ, Cleghorn JM, Brown GM, et al. 1988 Seasonal variations in prolactin levels in schizophrenia. Psychiatry Res. 25:157-162.
49. Lacoste V, Wirz-Justice A. 1989 Seasonal variation in normal subjects: an uptake of variables current in depression research. In: Rosenthal NE, Blehar MC, eds. Seasonal affective disorders and phototherapy. New York: Guilford Press; 167-229.
50. Mueller EA, Murphy DL, Sunderland T. 1986 Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology. 89:388-391.
51. O'Keane V, O'Hanlon M, Webb M, Dinan T. 1991 d-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clin Endocrinol (Oxf). 34:289-292.
52. Murphy DL, Lesch KP, Aulakh CS, Pigott TA. 1991 Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev. 43:527-552.
53. Hoyer D, Clarke DE, Fozard JR, et al. 1991 International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46:157-203.
54. 2C receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology. 119:222-230.
55. Murphy DL, Aulakh C, Mazzola-Pomietto P, Briggs NC. 1996 Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: a preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Behav Brain Res. 73:209-214.